JP6458035B2 - インプラント周囲炎の予防および／または治療のための製剤 - Google Patents

インプラント周囲炎の予防および／または治療のための製剤 Download PDF

Info

Publication number
JP6458035B2
JP6458035B2 JP2016537431A JP2016537431A JP6458035B2 JP 6458035 B2 JP6458035 B2 JP 6458035B2 JP 2016537431 A JP2016537431 A JP 2016537431A JP 2016537431 A JP2016537431 A JP 2016537431A JP 6458035 B2 JP6458035 B2 JP 6458035B2
Authority
JP
Japan
Prior art keywords
use according
aqueous component
peri
implantitis
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2016537431A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016539959A5 (https=
JP2016539959A (ja
Inventor
ウルリーカ・アルモイド
ヤン・フォーネル
Original Assignee
アルエルエス グローバル アーベー
アルエルエス グローバル アーベー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アルエルエス グローバル アーベー, アルエルエス グローバル アーベー filed Critical アルエルエス グローバル アーベー
Publication of JP2016539959A publication Critical patent/JP2016539959A/ja
Publication of JP2016539959A5 publication Critical patent/JP2016539959A5/ja
Application granted granted Critical
Publication of JP6458035B2 publication Critical patent/JP6458035B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/20—Elemental chlorine; Inorganic compounds releasing chlorine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/20—Halogens; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0063—Periodont
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/88—Two- or multipart kits
    • A61K2800/882—Mixing prior to application

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
JP2016537431A 2013-12-09 2014-12-08 インプラント周囲炎の予防および／または治療のための製剤 Active JP6458035B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
SE1351468 2013-12-09
SE1351468-2 2013-12-09
SE1450452-6 2014-04-11
SE1450452 2014-04-11
PCT/EP2014/076909 WO2015086535A1 (en) 2013-12-09 2014-12-08 Preparation for prevention and/or treatment of peri-implantitis

Publications (3)

Publication Number Publication Date
JP2016539959A JP2016539959A (ja) 2016-12-22
JP2016539959A5 JP2016539959A5 (https=) 2018-01-18
JP6458035B2 true JP6458035B2 (ja) 2019-01-23

Family

ID=52014107

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016537431A Active JP6458035B2 (ja) 2013-12-09 2014-12-08 インプラント周囲炎の予防および／または治療のための製剤

Country Status (4)

Country Link
US (1) US20160310525A1 (https=)
EP (1) EP3079657B8 (https=)
JP (1) JP6458035B2 (https=)
WO (1) WO2015086535A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12558335B2 (en) * 2019-09-19 2026-02-24 Rls Global Ab Preparation for removal and/or prevention of an infection associated with Staphylococcus epidermidis
RU2760169C1 (ru) * 2021-02-05 2021-11-22 Федеральное государственное бюджетное военное образовательное учреждение высшего образования "Военно-медицинская академия имени С.М. Кирова" Министерства обороны Российской Федерации (ВМедА) Способ профилактики осложнений после установки дентальных имплантатов

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE507437C2 (sv) * 1996-11-14 1998-06-08 Medi Team Dentalutveckling I G Preparat för användning vid kemisk-mekanisk behandling av kariesangrepp och förfarande för framställning av preparatet
NL2004260C2 (en) * 2010-02-18 2011-08-22 Univ Amsterdam Disinfectant composition and its use in dental treatment.
JP5952899B2 (ja) * 2011-06-15 2016-07-13 アルエルエス グローバル アーベー う蝕象牙質組織の検出と除去

Also Published As

Publication number Publication date
WO2015086535A1 (en) 2015-06-18
JP2016539959A (ja) 2016-12-22
EP3079657A1 (en) 2016-10-19
US20160310525A1 (en) 2016-10-27
EP3079657B8 (en) 2019-05-15
EP3079657B1 (en) 2019-03-20

Similar Documents

Publication Publication Date Title
Barootchi et al. Peri-implant diseases: Current understanding and management
Yildiz et al. Evaluation of formocresol, calcium hydroxide, ferric sulfate, and MTA primary molar pulpotomies
Chambers et al. Oral and dental management of the cancer patient: prevention and treatment of complications
Srinivasan et al. Ozone: A paradigm shift in dental therapy
Salem et al. Efficacy of diode laser application versus silver diamine fluoride (SDF) as a modification of Hall technique in primary teeth
Issrani et al. Exploring the properties of formocresol in dentistry---a comprehensive review.
Sghaireen et al. Effect of aqueous ozone solution irrigation on healing after treatment with dental implants: a cross-over randomized controlled clinical trial
JP6458035B2 (ja) インプラント周囲炎の予防および／または治療のための製剤
Balachandran et al. Evaluation of efficacy of chemo-mechanical method of caries removal using Brix-3000 compared to conventional excavation with burs-A randomized controlled trial.
US10226403B2 (en) Composition and method for using medicament for endodontic irrigation, stem cell preparation and tissue regeneration
Poli et al. Adjunctive use of antimicrobial photodynamic therapy in the surgical treatment of periapical lesions: a case series
Samuelsson et al. Nonsurgical Treatment of Peri-implantitis Using a Chitosan Brush with Adjunctive Chemical Decontaminants--A Retrospective Case Series.
US9730862B2 (en) Composition and method for using medicament for endodontic irrigation, stem cell preparation and tissue regeneration
Kaur et al. Using laser therapy and topical ozone as an effective intervention to revolutionize denture stomatitis treatment: A case report
Porenczuk et al. Peri-implantitis: A Serious Problem of Dental Implantology
Zholdassova et al. Efficacy of minimally invasive therapy and laser therapy in the comprehensive treatment of endoperiodontal lesions
Arısan et al. Photodynamic Therapy as an Adjunct to Resective and Regenerative Surgical Treatment of Peri-Implantitis: A Prospective Cohort of 72 Patients Followed for 18 Months
Khan et al. Orthograde nonsurgical endodontic therapy of a molar with periapical radiolucency by employing the rotary files and adjunctive laser-assisted disinfection in a claustrophobic pediatric patient: a rare case report with literature review
Abd-Ul-Salam Peri-implantitis
Ho Biological Complications
Wang et al. Comparison of clinical outcomes between mineral trioxide aggregate and bioceramic materials in pulpotomy for treating early chronic pulpitis in deciduous teeth.
Finor A Retrospective Analysis of Lesion Sterilization and Tissue Repair Versus Pulpectomy Success
Lee et al. Understanding, identifying and treating peri-implantitis: Identifying and managing peri-implantitis
Tavares et al. Surgical Approach to the Treatment of Advanced Periimplantitis: Case Report
RU2296532C2 (ru) Способ парарадикулярного аутографтинга

Legal Events

Date Code Title Description
A529 Written submission of copy of amendment under article 34 pct

Free format text: JAPANESE INTERMEDIATE CODE: A529

Effective date: 20160620

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20171127

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20171127

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20180807

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20181024

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20181204

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20181221

R150 Certificate of patent or registration of utility model

Ref document number: 6458035

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313113

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250